Digoxin and Topotecan drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Digoxin (digoxin) and Topotecan (topotecan hydrochloride). Common drug interactions include neutropenia among females and diarrhoea among males.
The phase IV clinical study analyzes what interactions people have when they take Digoxin and Topotecan. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.
What is Digoxin?
Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 93,740 Digoxin users. Check the latest studies of Digoxin.
What is Topotecan?
Topotecan has active ingredients of topotecan hydrochloride. eHealthMe is studying from 5,853 Topotecan users. Check the latest studies of Topotecan.
16 people who take Digoxin and Topotecan together, and have interactions are studied.

What are the common drug interactions of Digoxin and Topotecan, by gender? *:
female:
- Neutropenia (an abnormally low number of neutrophils)
- Diarrhoea
- Death
- Fatigue (feeling of tiredness)
- Herpes zoster
- Hypoaesthesia (reduced sense of touch or sensation)
- Lymphadenopathy (disease or enlargement of lymph nodes)
- Pneumonia
- Productive cough
- Rash pruritic (redness with itching)
male:
- Diarrhoea
- Neutropenia (an abnormally low number of neutrophils)
- Bone marrow failure
- Cardiac failure
- Intestinal obstruction
- Anaemia (lack of blood)
- Aortic aneurysm rupture (enlarged aortic artery rapture caused by a weakening of the artery wall)
- Appendicitis (inflammation of the appendix)
- Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
- Asbestosis (chronic lung disease caused by scarring of lung tissue, which stems from prolonged exposure to asbestos)
What are the common drug interactions of Digoxin and Topotecan, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Drug toxicity
- Fungaemia (fungi circulate in the blood)
- Hypocalcaemia (levels of calcium in blood serum are abnormally low)
- Hypoxia (low oxygen in tissues)
- Multi-organ failure (multisystem organ failure)
- Neutropenia (an abnormally low number of neutrophils)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Venous thrombosis deep limb (blood clot that forms in a vein deep in the limb)
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Diarrhoea
- Neutropenia (an abnormally low number of neutrophils)
- Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
- Productive cough
- Weight decreased
- Back pain
- Blood potassium increased
- Renal failure (kidney dysfunction)
- Abdominal discomfort
- Alopecia (absence of hair from areas of the body)
What are the existing conditions these people have? *
- High Blood Pressure: 3 people, 18.75%
- Diarrhea: 3 people, 18.75%
- Lung Cancer - Small Cell (lung cancer): 3 people, 18.75%
- Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 18.75%
- Type 2 Diabetes: 2 people, 12.50%
- Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 2 people, 12.50%
- Abdominal Pain Upper: 2 people, 12.50%
- Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 12.50%
- Pain In Extremity: 2 people, 12.50%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 12.50%
* Approximation only. Some reports may have incomplete information.
Do you take Digoxin and Topotecan?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Digoxin and Topotecan:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Digoxin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Topotecan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Digoxin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Topotecan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
- Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
- Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
- Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
How the study uses the data?
The study uses data from the FDA. It is based on digoxin and topotecan hydrochloride (the active ingredients of Digoxin and Topotecan, respectively), and Digoxin and Topotecan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Tofacitinib cause Vomiting Aggravated? - 2 seconds ago
- Drug interactions of Glycolax and Fluticasone Propionate - 6 seconds ago
- Could Morphine cause Serositis? - 8 seconds ago
- Could Tolterodine cause Breast Cancer? - 8 seconds ago
- Could Niaspan cause Glucose Tolerance Impaired? - 8 seconds ago
- Could Nicotinamide cause Constipation? - 12 seconds ago
- Drug interactions of Linezolid and Mycamine - 15 seconds ago
- Could Tolterodine Tartrate cause Abdominal Discomfort? - 16 seconds ago
- Could Antivert cause Skin Tightness? - 17 seconds ago
- Drug interactions of Sodium Fluoride and Clonidine Hydrochloride - 19 seconds ago